Last reviewed · How we verify
Flavonil® cps
Flavonil is a flavonoid-based antioxidant that reduces oxidative stress and inflammation through free radical scavenging.
Flavonil is a flavonoid-based antioxidant that reduces oxidative stress and inflammation through free radical scavenging. Used for Vascular insufficiency and microcirculation disorders.
At a glance
| Generic name | Flavonil® cps |
|---|---|
| Sponsor | University of Roma La Sapienza |
| Drug class | Antioxidant/Flavonoid |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
Flavonil contains flavonoid compounds that act as antioxidants by neutralizing reactive oxygen species and reducing lipid peroxidation. These compounds modulate inflammatory pathways and may improve vascular endothelial function. The mechanism is primarily cytoprotective rather than targeting a specific receptor.
Approved indications
- Vascular insufficiency and microcirculation disorders
Common side effects
- Gastrointestinal disturbances
- Headache
- Dizziness
Key clinical trials
- Pain and Bleeding in Subjects With Acute Anal Fissure: Comparative Evaluation of Three Treatments (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flavonil® cps CI brief — competitive landscape report
- Flavonil® cps updates RSS · CI watch RSS
- University of Roma La Sapienza portfolio CI